Treatment after the Failure of Gefitinib in Patients with Advanced or Recurrent Non-small Cell Lung CancerMARUYAMA, Riichiroh; WATAYA, Hiroshi; SETO, Takashi et al.Anticancer research. 2009, Vol 29, Num 10, pp 4217-4221, issn 0250-7005, 5 p.Article

Phase III Study Comparing Second- and Third-Generation Regimens With Concurrent Thoracic Radiotherapy in Patients With Unresectable Stage III Non-Small-Cell Lung Cancer: West Japan Thoracic Oncology Group WJTOG0105YAMAMOTO, Nobuyuki; NAKAGAWA, Kazuhiko; SAWA, Toshiyuki et al.Journal of clinical oncology. 2010, Vol 28, Num 23, pp 3739-3745, issn 0732-183X, 7 p.Article

Phase I/II trial of gemcitabine plus oral TS-1 in elderly patients with advanced non-small cell lung cancer: Thoracic oncology research group study 0502SETO, Takashi; YAMANAKA, Takeharu; ICHINOSE, Yukito et al.Lung cancer. 2010, Vol 69, Num 2, pp 213-217, issn 0169-5002, 5 p.Article

Predictive factors for interstitial lung disease, antitumor response, and survival in non-small-cell lung cancer patients treated with gefitinibANDO, Masahiko; OKAMOTO, Isamu; YAMAMOTO, Nobuyuki et al.Journal of clinical oncology. 2006, Vol 24, Num 16, pp 2549-2556, issn 0732-183X, 8 p.Article

Prognostic Factors in Non-small Cell Lung Cancer Patients with Postoperative Recurrence Following Third-Generation ChemotherapyYAMAZAKI, Koji; SUGIO, Kenji; YAMANAKA, Takeharu et al.Anticancer research. 2010, Vol 30, Num 4, pp 1311-1315, issn 0250-7005, 5 p.Article

Phase III study of docetaxel compared with vinorelbine in elderly patients with advanced non-small-cell lung cancer : Results of the west japan thoracic oncology group trial (WJTOG 9904)KUDOH, Shinzoh; TAKEDA, Koji; SETO, Takashi et al.Journal of clinical oncology. 2006, Vol 24, Num 22, pp 3657-3663, issn 0732-183X, 7 p.Article

A prospective, phase II, open-label study (JO22903) of first-line erlotinib in Japanese patients with epidermal growth factor receptor (EGFR) mutation-positive advanced non-small-cell lung cancer (NSCLC)GOTO, Koichi; NISHIO, Makoto; FUKUYAMA, Tamaki et al.Lung cancer. 2013, Vol 82, Num 1, pp 109-114, issn 0169-5002, 6 p.Article

PHASE I RESULTS OF VINORELBINE WITH CONCURRENT RADIOTHERAPY IN ELDERLY PATIENTS WITH UNRESECTABLE, LOCALLY ADVANCED NON-SMALL-CELL LUNG CANCER: WEST JAPAN THORACIC ONCOLOGY GROUP (WJTOG3005-DI)HARADA, Hideyuki; SETO, Takashi; YAMAMOTO, Nobuyuki et al.International journal of radiation oncology, biology, physics. 2012, Vol 82, Num 5, pp 1777-1782, issn 0360-3016, 6 p.Article

Multiple pulmonary metastases of lung adenocarcinoma to a different ipsilateral lobe after pulmonary lobectomyOKAMOTO, Tatsuro; MARUYAMA, Riichiroh; SETO, Takashi et al.Lung cancer. 2007, Vol 56, Num 3, pp 449-453, issn 0169-5002, 5 p.Article

The first case of lung carcinosarcoma harboring in-frame deletions at exon19 in the EGFR geneTOYOKAWA, Gouji; TAKENOYAMA, Mitsuhiro; HIRAI, Fumihiko et al.Lung cancer. 2013, Vol 81, Num 3, pp 491-494, issn 0169-5002, 4 p.Article

Signet ring cell adenocarcinoma of the lung with an EML4―ALK fusion gene mimicking mucinous (colloid) adenocarcinoma: A case reportOHBA, Taro; SUGIO, Kenji; TAGUCHI, Kenichi et al.Lung cancer. 2011, Vol 73, Num 3, pp 375-378, issn 0169-5002, 4 p.Article

Prognostic factors in previously treated non-small cell lung cancer patients with and without a positive response to the subsequent treatment with gefitinibWATAYA, Hiroshi; OKAMOTO, Tatsuro; YAMANAKA, Takeharu et al.Lung cancer. 2009, Vol 64, Num 3, pp 341-345, issn 0169-5002, 5 p.Article

Targeting the Wnt Signaling Pathway with Dishevelled and Cisplatin Synergistically Suppresses Mesothelioma Cell GrowthUEMATSU, Kazutsugu; SEKI, Nobuhiko; EGUCHI, Kenji et al.Anticancer research. 2007, Vol 27, Num 6B, pp 4239-4242, issn 0250-7005, 4 p.Article

Prognostic value of expression of vascular endothelial growth factor and its flt-1 and KDR receptors in stage I non-small-cell lung cancerSETO, Takashi; HIGASHIYAMA, Masahiko; FUNAI, Hiroko et al.Lung cancer. 2006, Vol 53, Num 1, pp 91-96, issn 0169-5002, 6 p.Article

An extremely rare case of small-cell lung cancer harboring variant 2 of the EML4-ALK fusion geneTOYOKAWA, Gouji; TAKENOYAMA, Mitsuhiro; YAMAGUCHI, Masafumi et al.Lung cancer. 2013, Vol 81, Num 3, pp 487-490, issn 0169-5002, 4 p.Article

Crizotinib versus Chemotherapy in Advanced ALK-Positive Lung CancerSHAW, Alice T; KIM, Dong-Wan; WU, Yi-Long et al.The New England journal of medicine. 2013, Vol 368, Num 25, pp 2385-2394, issn 0028-4793, 10 p.Article

Phase I, dose-escalation study of AZD7762 alone and in combination with gemcitabine in Japanese patients with advanced solid tumoursSETO, Takashi; ESAKI, Taito; AGBO, Felix et al.Cancer chemotherapy and pharmacology. 2013, Vol 72, Num 3, pp 619-627, issn 0344-5704, 9 p.Article

Randomized Phase III Trial of Platinum-Doublet Chemotherapy Followed by Gefitinib Compared With Continued Platinum-Doublet Chemotherapy in Japanese Patients With Advanced Non―Small-Cell Lung Cancer: Results of a West Japan Thoracic Oncology Group Trial (WJTOG0203)TAKEDA, Koji; HIDA, Toyoaki; SASAKI, Jiichiro et al.Journal of clinical oncology. 2010, Vol 28, Num 5, pp 753-760, issn 0732-183X, 8 p.Article

Phase III Trial Comparing Oral S-1 Plus Carboplatin With Paclitaxel Plus Carboplatin in Chemotherapy-Naïve Patients With Advanced Non-Small-Cell Lung Cancer: Results of a West Japan Oncology Group StudyOKAMOTO, Isamu; YOSHIOKA, Hiroshige; KUDOH, Shinzoh et al.Journal of clinical oncology. 2010, Vol 28, Num 36, pp 5240-5246, issn 0732-183X, 7 p.Article

Persistent and aggressive treatment for thymic carcinoma : Results of a single-institute experience with 25 patientsMARUYAMA, Riichiroh; SUEMITSU, Ryuichi; OKAMOTO, Tatsuro et al.Oncology. 2006, Vol 70, Num 5, pp 325-329, issn 0030-2414, 5 p.Article

Phase II trial of amrubicin for treatment of refractory or relapsed small-cell lung cancer : Thoracic oncology research group study 0301ONODA, Sayaka; MASUDA, Noriyuki; ASAKA-AMANO, Yoshiko et al.Journal of clinical oncology. 2006, Vol 24, Num 34, pp 5448-5453, issn 0732-183X, 6 p.Article